Search alternatives:
values decrease » values increased (Expand Search), largest decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
Showing 1,661 - 1,680 results of 5,843 for search '(( ct ((values decrease) OR (larger decrease)) ) OR ( a ((mean decrease) OR (linear decrease)) ))', query time: 0.59s Refine Results
  1. 1661
  2. 1662
  3. 1663
  4. 1664
  5. 1665
  6. 1666
  7. 1667
  8. 1668
  9. 1669
  10. 1670

    Acceptance of the HPV vaccine. by Mohammad Delwer Hossain Hawlader (11558838)

    Published 2024
    “…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
  11. 1671

    Cues to the action question. by Mohammad Delwer Hossain Hawlader (11558838)

    Published 2024
    “…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
  12. 1672

    Characteristics of the respondents (n = 2,151). by Mohammad Delwer Hossain Hawlader (11558838)

    Published 2024
    “…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
  13. 1673

    Determinants of HPV vaccine acceptance. by Mohammad Delwer Hossain Hawlader (11558838)

    Published 2024
    “…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
  14. 1674

    Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  15. 1675

    Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  16. 1676

    Characteristics of the included studies. by Si He (3236646)

    Published 2025
    “…The pooling of dichotomous outcome data was achieved using relative risk (RR), with results presented within a 95% confidence interval (CI). We utilized the standard mean difference (SMD) and 95% CI for continuous outcomes. …”
  17. 1677

    Extracted data and used for analysis. by Si He (3236646)

    Published 2025
    “…The pooling of dichotomous outcome data was achieved using relative risk (RR), with results presented within a 95% confidence interval (CI). We utilized the standard mean difference (SMD) and 95% CI for continuous outcomes. …”
  18. 1678

    Excluded studies with reasons for exclusion. by Si He (3236646)

    Published 2025
    “…The pooling of dichotomous outcome data was achieved using relative risk (RR), with results presented within a 95% confidence interval (CI). We utilized the standard mean difference (SMD) and 95% CI for continuous outcomes. …”
  19. 1679
  20. 1680